US Stock MarketDetailed Quotes

Citius Oncology (CTOR)

Watchlist
  • 0.6422
  • -0.0217-3.27%
Close Apr 8 16:00 ET
56.69MMarket Cap-2.07P/E (TTM)

Citius Oncology (CTOR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.35M
-4,446.59%-5.49M
-4,446.59%-5.49M
0
0
0
126.35K
126.35K
0
0
Net income from continuing operations
16.90%-5.53M
-17.08%-24.76M
26.66%-5M
-12.51%-5.37M
-59.97%-7.74M
-40.86%-6.66M
-66.56%-21.15M
---6.81M
---4.77M
---4.84M
Depreciation and amortization
--573.44K
----
----
----
----
--0
----
----
----
----
Deferred tax
0.00%264.24K
83.50%1.06M
83.50%264.24K
83.50%264.24K
83.50%264.24K
83.50%264.24K
0.00%576K
--144K
--144K
--144K
Change In working capital
-244.22%-6.61M
-25.06%9.89M
-159.63%-3.06M
11.55%2.98M
96.84%5.38M
72.01%4.59M
29.98%13.2M
--5.13M
--2.67M
--2.73M
-Change in receivables
---4.05M
----
----
----
----
--0
----
----
----
----
-Change in inventory
94.23%-352.65K
-492.78%-12.65M
-73.82%-3.71M
---1.87M
---957.88K
---6.11M
---2.13M
---2.13M
----
----
-Change in prepaid assets
---1.83M
--0
-236.53%-1.6M
----
----
--0
78.19%-1.1M
--1.17M
---1.1M
---1.17M
-Change in payables and accrued expense
-103.56%-381.19K
37.16%22.54M
-63.03%2.25M
-13.83%3.25M
62.31%6.34M
301.26%10.7M
8.12%16.43M
--6.09M
--3.77M
--3.91M
Cash from discontinued investing activities
Operating cash flow
---7.35M
-4,446.59%-5.49M
-4,446.59%-5.49M
--0
--0
--0
--126.35K
--126.35K
--0
--0
Investing cash flow
Cash flow from continuing investing activities
-4.4M
-15.00%-5.75M
0
-5M
Net intangibles purchase and sale
---4.4M
-15.00%-5.75M
----
----
----
--0
---5M
----
----
----
Cash from discontinued investing activities
Investing cash flow
---4.4M
-15.00%-5.75M
----
----
----
--0
---5M
----
----
----
Financing cash flow
Cash flow from continuing financing activities
15.13M
211.19%15.17M
0
4.87M
Net issuance payments of debt
----
--0
----
----
----
----
--3.8M
----
----
----
Net common stock issuance
--15.13M
--15.17M
----
----
----
--0
--0
----
----
----
Net other financing activities
----
----
----
----
----
----
--1.07M
----
----
----
Cash from discontinued financing activities
Financing cash flow
--15.13M
211.19%15.17M
----
----
----
--0
--4.87M
----
----
----
Net cash flow
Beginning cash position
3,504,282.14%3.92M
--112
--112
--112
--112
--112
--0
--0
--0
--0
Current changes in cash
--3.37M
3,504,182.14%3.92M
----
----
----
----
--112
----
----
----
End cash Position
6,513,695.54%7.3M
3,504,282.14%3.92M
3,504,282.14%3.92M
--112
--112
--112
--112
--112
--0
--0
Free cash flow
---11.75M
-130.67%-11.24M
-130.67%-11.24M
--0
--0
--0
---4.87M
---4.87M
--0
--0
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.35M-4,446.59%-5.49M-4,446.59%-5.49M000126.35K126.35K00
Net income from continuing operations 16.90%-5.53M-17.08%-24.76M26.66%-5M-12.51%-5.37M-59.97%-7.74M-40.86%-6.66M-66.56%-21.15M---6.81M---4.77M---4.84M
Depreciation and amortization --573.44K------------------0----------------
Deferred tax 0.00%264.24K83.50%1.06M83.50%264.24K83.50%264.24K83.50%264.24K83.50%264.24K0.00%576K--144K--144K--144K
Change In working capital -244.22%-6.61M-25.06%9.89M-159.63%-3.06M11.55%2.98M96.84%5.38M72.01%4.59M29.98%13.2M--5.13M--2.67M--2.73M
-Change in receivables ---4.05M------------------0----------------
-Change in inventory 94.23%-352.65K-492.78%-12.65M-73.82%-3.71M---1.87M---957.88K---6.11M---2.13M---2.13M--------
-Change in prepaid assets ---1.83M--0-236.53%-1.6M----------078.19%-1.1M--1.17M---1.1M---1.17M
-Change in payables and accrued expense -103.56%-381.19K37.16%22.54M-63.03%2.25M-13.83%3.25M62.31%6.34M301.26%10.7M8.12%16.43M--6.09M--3.77M--3.91M
Cash from discontinued investing activities
Operating cash flow ---7.35M-4,446.59%-5.49M-4,446.59%-5.49M--0--0--0--126.35K--126.35K--0--0
Investing cash flow
Cash flow from continuing investing activities -4.4M-15.00%-5.75M0-5M
Net intangibles purchase and sale ---4.4M-15.00%-5.75M--------------0---5M------------
Cash from discontinued investing activities
Investing cash flow ---4.4M-15.00%-5.75M--------------0---5M------------
Financing cash flow
Cash flow from continuing financing activities 15.13M211.19%15.17M04.87M
Net issuance payments of debt ------0------------------3.8M------------
Net common stock issuance --15.13M--15.17M--------------0--0------------
Net other financing activities --------------------------1.07M------------
Cash from discontinued financing activities
Financing cash flow --15.13M211.19%15.17M--------------0--4.87M------------
Net cash flow
Beginning cash position 3,504,282.14%3.92M--112--112--112--112--112--0--0--0--0
Current changes in cash --3.37M3,504,182.14%3.92M------------------112------------
End cash Position 6,513,695.54%7.3M3,504,282.14%3.92M3,504,282.14%3.92M--112--112--112--112--112--0--0
Free cash flow ---11.75M-130.67%-11.24M-130.67%-11.24M--0--0--0---4.87M---4.87M--0--0
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More